Resistance to Ciprofloxacin in Urinary Tract Infection
Abstract
Introduction: Urinary tract infections (UTIs) are one of the most common infectious diseases worldwide.Approximately >50% of women at least once in their lifetime have suffered from UTI and received antibiotic treatment.Serious UTIs are difficult to treat as it involves a wide array of Gram-positive as well as Gram-negative bacteria.Escherichia coli (E.coli) is the primary causative agent implicated in >80% of UTI cases.Current approach to treatment: A variety of drugs are indicated for the treatment of various clinical forms of UTI.These include nitrofurantoin, cotrimoxazole,fluoroquinolones, some cephalosporins, piperacillin-tazobactam, meropenem, ertapenem etc.Recently various studies have repor ted ciprofloxacin resistance among E. coli, the most common uropathogen. Review of literature pertaining to ciprofloxacin resistance:The prevalence, factors contributing to resistance and mechanism thereof have been reviewed.Hence, it is necessary to rationalize the use of ciprofloxacin to control the threat of antibiotic resistance. Conclusion:The incidence of resistance to ciprofloxacin has increased steadily during the past few years.Thus, the empirical use of fluoroquinolones for treatment of UTI should be reconsidered and the drug used only whenthere are clear laboratory tests confirming sensitivity to the drug.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.